Apex Molecular Celebrates 10th Anniversary

Apex Molecular, a leading UK based chemistry contract research organisation celebrates its 10th anniversary at the end of March 2021.

Starting out on the University of Leeds Campus, with one lab and two employees, and a focus on catalysis chemistry, the company has grown and developed its capabilities and expertise to become a leading provider of synthetic chemistry services, including custom/contract synthesis, medicinal chemistry, high potency synthesis and scale up development.

Milestones in our journey include expanding the Leeds facility and the company to seven employees, before relocating to Alderley Park in May 2015 to allow further expansion. Since relocating to our current facilities in Alderley Park, the business has grown markedly, with turnover increasing six fold and staff numbers increasing five fold.

The ethos of the business has always been to make a difference – enabling our customer’s to meet, or rather exceed their visions. To do this, in addition to offering the expert chemistry services mentioned above, we have focused on providing first class communication and transparency with our customers so that we become a trusted partner and almost an extension of their organisation.

As we move into our second decade the future remains bright, we continue to expand our capabilities by employing new staff with chemistry expertise in areas such as medicinal chemistry, antibody drug conjugates, nucleosides, polymers, catalysis and the more. We continue to add additional equipment such as our new Waters Acquity UPLCMS for rapid reaction analysis, and expand into additional lab facilities as our overall numbers increase.

With a strong customer base in the UK and US pharm, biotech, agritech and advanced materials sectors, the next ten years look every bit as bright for Apex Molecular.

Stuart Brown Apex Molecular’s CEO commented, ‘Having been on the company journey for 7 of the 10 years I have participated in most of the growth and it has been a privilege to work with the excellent team we have. Without their professionalism and dedication we would not be the company we are today, or more importantly, the company we will be in the coming years.’

Tom Screen, Apex Molecular’s COO commented, ‘Having been with the company since the beginning it is hugely satisfying and rewarding to see the growth of the business and in particular the development of our team. We still strive to give all our projects and customers the same care and attention to details as on day one.’